Zinc finger nucleases: A new era for transgenic animals

Annals of Neurosciences

Volumn 18, Issue 1, 2011, Pages 25-28

  Swarthout, John T ^a   Raisinghani, Manish ^b   Cui, Xiaoxia ^b  

^a Sigma Aldrich Co   (United States)

^b Sigma Advanced Genetic Engineering SAGE Labs   (United States)

Author keywords

Animal models; Cell lines; DNA repair; Homologous recombination; Non homologous end joining; Zinc finger nuclease

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; DJ 1 PROTEIN; DOPAMINE; NUCLEASE; PARKIN; PARKIN 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN PINK1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; DNA REPAIR; DOUBLE STRANDED DNA BREAK; GENETIC ENGINEERING; NONHUMAN; PARKINSON DISEASE; PROTEIN EXPRESSION; REVIEW; TRANSGENIC ANIMAL;

EID: 79960130223     PISSN: 09727531     EISSN: 09763260     Source Type: Journal    
DOI: 10.5214/ans.0972.7531.1118109     Document Type: Review

References (46)

1. Urnov FD, Rebar EJ, Holmes MC, et al. Genome editing with engineered zinc finger nucleases. Nat Rev Genet 2010; 11: 636-646.
2. Capecchi MR. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genet 2005; 6: 507-512.
3. Abbott A. Laboratory animals: the Renaissance rat. Nature 2004; 428: 464-466.
4. Cozzi J, Fraichard A and Thiam K. Use of genetically modified rat models for translational medicine. Drug Discov Today 2008; 13: 488-494.
5. Lindblad-Toh, K. Genome sequencing: three's company. Nature 2004; 428: 475-476.
6. Graf LH, Jr and Chasin LA. Direct demonstration of genetic alterations at the dihydrofolate reductase locus after gamma irradiation. Mol Cell Biol 1982; 2: 93-96.
7. O'Brien TP and Frankel WN. Moving forward with chemical mutagenesis in the mouse. J Physiol 2004; 554: 13-21.
8. Zan Y, Haag JD, Chen KS, et al. Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat Biotechnol 2003; 21: 645-651.
9. Smits BM, Mudde JB, van de Belt J, et al. Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis. Pharmacogenet Genomics 2006; 16: 159-169.
10. Wienholds E, Van Eeden F, Kosters M, et al. Efficient target-selected mutagenesis in zebrafish. Genome Res 2003; 13: 2700-2707.
11. Kitada K, Ishishita S, Tosaka K, et al. Transposon- tagged mutagenesis in the rat. Nat Methods 2007; 4: 131-133.
12. Lu B, Geurts AM, Poirier C, et al. Generation of rat mutants using a coat color-tagged Sleeping Beauty transposon system. Mamm Genome 2007; 18: 338-346.
13. Bugos O, Bhide M and Zilka N. Beyond the rat models of human neurodegenerative disorders. Cell Mol Neurobiol 2009; 29: 859-869.
14. Aitman TJ, Critser JK, Cuppen E, et al. Progress and prospects in rat genetics: a community view. Nat Genet 2008; 40: 516-522.
15. Buehr M, Meek S, Blair K, et al. Capture of authentic embryonic stem cells from rat blastocysts. Cell 2008; 135: 1287-1298.
16. Li P, Tong C, Mehrian-Shai R, et al. Germline competent embryonic stem cells derived from rat blastocysts. Cell 2008; 135: 1299-1310.
17. Tong C, Li P, Wu NL, et al. Production of p53 gene knockout rats by homologous recombination in embryonic stem cells. Nature 2010; 467: 211-213.
18. Kim YG, Cha J and Chandrasegaran S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A 1996; 93: 1156-1160.
19. Bibikova M, Carroll D, Segal DJ, et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol Cell Biol 2001; 21: 289-297.
20. Durai S, Mani M, Kandavelou K, et al. Zinc finger nucleases: custom-designed molecular scissors for genome engineering of plant and mammalian cells. Nucleic Acids Res 2005; 33: 5978-5990.
21. Porteus MH and Carroll D. Gene targeting using zinc finger nucleases. Nat Biotechnol 2005; 23: 967-973.
22. Geurts AM, Cost GJ, Freyvert Y, et al. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 2009; 325: 433.
23. Mashimo T, Takizawa A, Voigt B, et al. Generation of knockout rats with X-linked severe combined immunodeficiency (X-SCID) using zinc-finger nucleases. PLoS One 2010; 5: 8870.
24. Carbery ID, Ji D, Harrington A, et al. Targeted Genome Modification in Mice Using Zinc Finger Nucleases. Genetics 2010; 186: 451-459.
25. Meyer M, De Angelis MH, Wurst W, et al. Gene targeting by homologous recombination in mouse zygotes mediated by zinc-finger nucleases. Proc Natl Acad Sci USA 2010; 107: 15022-15026.
26. Michalkiewicz M, Michalkiewicz T, Geurts AM, et al. Efficient transgenic rat production by a lentiviral vector. Am J Physiol Heart Circ Physiol 2007; 293: 881-894.
27. Bredesen DE, Rao RV and Mehlen P. Cell death in the nervous system. Nature 2006; 443: 796-802.
28. Rubinsztein DC. The roles of intracellular protein- degradation pathways in neurodegeneration. Nature 2006; 443: 780-786.
29. Jankovic J. Parkinson's disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 79: 368-376.
30. Savitt JM, Dawson, VL and Dawson TM. Diagnosis and treatment of Parkinson disease: molecules to medicine. J Clin Invest 2006; 116: 1744-1754.
31. Dawson TM, Ko HS and Dawson VL. Genetic animal models of Parkinson's disease. Neuron 2010; 66: 646-661.
32. Lesage S and Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009; 18: R48-59.
33. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004; 44: 595-600.
34. Smith WW, Pei Z, Jiang H, et al. Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc Natl Acad Sci U S A 2005; 102: 18676-18681.
35. Kitada T, Asakawa S, Hattori N, et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998; 392: 605-608.
36. Lucking CB, Durr A, Bonifati V, et al. Association between early-onset Parkinson's disease and mutations in the parkin gene. N Engl J Med 2000; 342: 1560-1567.
37. Gasser T. Molecular pathogenesis of Parkinson disease: insights from genetic studies. Expert Rev Mol Med 2009; 11: e22.
38. Bonifati V, Rizzu P, van Baren MJ, et al. Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 2003; 299: 256-259.
39. Niki T, Takahashi-Niki K, Taira T, et al. DJBP: a novel DJ-1-binding protein, negatively regulates the androgen receptor by recruiting histone deacetylase complex, and DJ-1 antagonizes this inhibition by abrogation of this complex. Mol Cancer Res 2003; 1: 247-261.
40. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005; 366: 2112-2117.
41. Sleegers K, Lambert JC, Bertram L, et al. The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet 2010; 26: 84-93.
42. Brouwers N, Sleegers K and Van Broeckhoven C. Molecular genetics of Alzheimer's disease: an update. Ann Med 2008; 40: 562-583.
43. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
44. Barde YA, Edgar D and Thoenen H. Purification of a new neurotrophic factor from mammalian brain. EMBO J 1982; 1: 549-553.
45. Binder DK and Scharfman HE. Brain-derived neurotrophic factor. Growth Factors 2004; 22: 123-131.
46. Murer MG, Yan Q and Raisman-Vozari R. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 2001; 63: 71-124.